This Hydrocortisone Acetate 1%/Miconazole 2%/Triple Antibiotic Topical Ointment is a semi-solid formulation dispensed in a tube, designed for external application to the skin. It features a greasy or oily base that enhances the delivery of active ingredients for localized treatment.
This ointment is specifically formulated to treat skin conditions such as inflammation, fungal infections, and bacterial infections.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This ointment is a compounded topical formulation containing Hydrocortisone Acetate 1%, Miconazole 2%, and a Triple Antibiotic combination. It is designed for external application to the skin to address various dermatological conditions involving inflammation and infections.
Hydrocortisone Acetate 1% is a corticosteroid that helps reduce inflammation, itching, and redness by suppressing the immune response in the affected area. This can provide relief from symptoms associated with inflammatory skin conditions.
It works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby treating and preventing fungal skin infections.
The Triple Antibiotic component typically includes bacitracin, neomycin, and polymyxin B. These antibiotics work synergistically to prevent and treat bacterial infections by inhibiting cell wall synthesis and disrupting vital bacterial processes, which is beneficial for wound healing and preventing infection in minor cuts, scrapes, and burns.
By combining these active ingredients in a greasy or oily ointment base, the formulation ensures prolonged contact with the skin, enhancing the absorption and effectiveness of the medications. This multi-action ointment is particularly useful for conditions where inflammation is accompanied by bacterial and fungal infections.
Patients using this formulation should apply it as directed by their healthcare provider, ensuring the affected area is clean
When using the Hydrocortisone Acetate 1%/Miconazole 2%/Triple Antibiotic Topical Ointment, it is important to be aware of potential drug interactions that may affect the efficacy and safety of the treatment. This formulation combines a corticosteroid, an antifungal, and a combination of antibiotics, which can interact with other medications or substances applied to the skin or taken systemically.
Hydrocortisone Acetate, a corticosteroid, may interact with other topical or systemic corticosteroids, potentially increasing the risk of systemic absorption and side effects such as skin thinning, increased blood sugar levels, or suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Patients using other corticosteroid-containing products should consult their healthcare provider to avoid excessive corticosteroid exposure.
Miconazole, an antifungal agent, can interact with certain medications metabolized by the cytochrome P450 enzyme system, particularly CYP3A4. Although systemic absorption from topical application is minimal, caution is advised when used concurrently with medications such as warfarin, as miconazole can enhance the anticoagulant effect, increasing the risk of bleeding. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements, to assess potential interactions.
The Triple Antibiotic component, typically consisting of bacitracin, neomycin, and polymyxin B, may interact with other topical antibiotics or antiseptics, potentially leading to reduced efficacy or increased risk of skin irritation. Additionally, neomycin is known to cause allergic reactions in some individuals, and concurrent use with other aminoglycosides should be avoided to prevent additive toxicity, particularly ototoxicity and nephrotoxicity.
Patients should avoid using other topical products on the same area unless directed by a healthcare provider, as this may alter the absorption and effectiveness of the ointment. It is also important to inform healthcare providers of any known allergies, particularly to corticosteroids, antifungals, or antibiotics, to prevent adverse reactions.
For prescribers, it is crucial to review the patient's current medication regimen and medical history to identify potential interactions and contraindications. Monitoring for signs of systemic absorption or adverse reactions is recommended, especially in long-term use or application over large surface areas.
If you have any questions or concerns regarding the use of this formulation or potential drug interactions, please reach out to us for further assistance.
The Hydrocortisone Acetate 1%/Miconazole 2%/Triple Antibiotic Topical Ointment is a carefully formulated semi-solid preparation designed for external application to the skin. This ointment is dispensed in a tube. The greasy or oily base of the ointment plays a crucial role in enhancing the absorption and retention of the active ingredients on the skin, ensuring prolonged contact and efficacy. This formulation is particularly beneficial for treating conditions such as skin inflammation, infections, and aiding in wound healing.
Hydrocortisone Acetate, a corticosteroid, is included in the formulation at a concentration of 1%. It works by reducing inflammation, redness, and swelling in the affected area. By inhibiting the release of inflammatory mediators, Hydrocortisone Acetate helps alleviate symptoms associated with inflammatory skin conditions, providing relief from itching and discomfort. This makes it an essential component for managing conditions like eczema, dermatitis, and other inflammatory dermatoses.
Miconazole, present at a 2% concentration, is an antifungal agent that targets fungal infections of the skin. It works by disrupting the cell membrane of fungi, leading to their death and preventing further growth. Its inclusion in the ointment ensures comprehensive treatment of mixed infections where both fungal and bacterial pathogens may be present.
The Triple Antibiotic component of the ointment consists of three antibiotics: Bacitracin, Neomycin, and Polymyxin B. These antibiotics work synergistically to combat a broad spectrum of bacterial infections. Bacitracin interferes with bacterial cell wall synthesis, Neomycin inhibits protein synthesis, and Polymyxin B disrupts the bacterial cell membrane.
This combination of active ingredients in a single ointment offers a multifaceted approach to treating skin conditions. By addressing inflammation, fungal infections, and bacterial infections simultaneously, the formulation provides comprehensive care, reducing the need for multiple separate treatments. The semi-solid nature of the ointment ensures that it remains in place on the skin, allowing for sustained action of the active ingredients.
It is important to apply the ointment as directed, typically to clean, dry skin, and to follow any additional instructions provided by a healthcare professional. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. We are here to assist you with any inquiries you may have.
This ointment is used for the treatment of skin conditions involving inflammation, infections, or wound healing. It combines anti-inflammatory, antifungal, and antibacterial properties to address various skin issues.
Apply a thin layer of the ointment to the affected area of the skin as directed by your healthcare provider. Ensure the area is clean and dry before application. Avoid contact with eyes, mouth, and other mucous membranes.
The frequency of application will depend on the specific condition being treated and the recommendation of your healthcare provider. Typically, it is applied 1-3 times daily.
This ointment can be used on minor cuts and abrasions, but it is important to follow your healthcare provider's instructions. Avoid using on large open wounds unless directed by a healthcare professional.
Some users may experience mild side effects such as skin irritation, redness, or itching at the application site. If you experience severe reactions or symptoms persist, contact your healthcare provider.
If you are pregnant or breastfeeding, consult your healthcare provider before using this ointment to ensure it is safe for you and your baby.
Consult a healthcare provider before using this ointment on children, as they may require specific dosing or considerations based on their age and condition.
Store the ointment at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
If you miss a dose, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not apply extra to make up for a missed dose.
Before using other skin products, consult your healthcare provider to avoid potential interactions or reduced effectiveness of the ointment. They can provide guidance on safe use with other products.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)